---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000366"
form_type: "8-K"
ticker: "ACHC"
cik: "0001520697"
company_name: "Acadia Healthcare Company, Inc."
filed_at: "2023-02-27T23:59:59+00:00"
generated_at: "2026-06-18T23:31:37.042019+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acadia Healthcare Q4 revenue up 13.8% to $675.3M; guides FY2023 adj. EPS $3.10-3.40

## Summary
- Q4 net income $61.1M ($0.67 diluted EPS); adjusted EPS $0.74, including $0.04 from CARES Act PRF.
- Same facility revenue +9.4% YoY on 5.2% revenue per patient day and 4.0% patient day growth.
- FY2023 guidance: revenue $2.82-2.88B, adj. EBITDA $635-675M, adj. EPS $3.10-3.40.
- Q1 2023 guidance: revenue $690-700M, adj. EBITDA $145-150M, adj. EPS $0.70-0.74.
- Added 80 beds in Q4; opened joint venture facility in Ft. Wayne and acquired four CTCs in Georgia.

## SEC filing metadata
- accession: 0001157523-23-000366
- form_type: 8-K
- ticker: ACHC
- cik: 0001520697
- company_name: Acadia Healthcare Company, Inc.
- filed_at: 2023-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/0001157523-23-000366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/a53352529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000366
- JSON: https://secwatch.observer/filing/0001157523-23-000366.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000366.txt

## Key facts
- Earnings Releases
  Acadia Healthcare Company, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $675.3 million, net income $61.1 million, EPS $0.67 per diluted share. Guidance initiated.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $675.3 million
  - Net income: $61.1 million
  - EPS: $0.67 per diluted share
  - Guidance: initiated
  - Result: reported results
  source text: Revenue totaled $675.3 million, an increase of 13.8% over the fourth quarter of 2021 Same facility revenue increased 9.4% compared to the fourth quarter of 2021, including an increase in revenue per patient day of 5.2% and an increase in patient days of 4.0% Net income attributable to Acadia totaled $61.1 million, or $0.67 per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/0001157523-23-000366-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.